English Reimbursement Win For Janssen’s Oral Multiple Sclerosis Drug
Ponvory Is Also Approved For Use On The NHS In Scotland
Executive Summary
The health technology assessment body for England and Wales (NICE) has reversed its initial rejection of Ponvory, giving people with relapsing-remitting multiple sclerosis a new oral treatment option.